Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Memry Corporation is a premier contract manufacturer specializing in Nitinol (nickel-titanium) shape memory alloys for the medical device industry. The company provides a full suite of services including alloy melting, wire drawing, tube manufacturing, and complex component fabrication for applications such as stents, guidewires, and heart valve frames. As a vertically integrated supplier, Memry offers 'melt-to-finish' capabilities that ensure high material quality and performance for critical medical implants. In 2023, the company was acquired by Resonetics from the SAES Group for approximately $900 million, integrating it into a broader micro-manufacturing portfolio. Memry is recognized for its deep expertise in material science, supporting medical device OEMs from early-stage prototyping through high-volume commercial production. Its facilities in Connecticut, California, and New York are ISO 13485 certified and serve global markets in cardiology, neurology, and orthopedics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Memry.